Company news
Fulcrum Therapeutics, Inc. news in 2025
Fulcrum Therapeutics, Inc.'s news releases, calls and decks from 2025, newest first.
Fulcrum Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering of Common Stock and Pre-Funded Warrants
December 9, 2025
Fulcrum Therapeutics Announces Proposed $150.0 Million Public Offering of Common Stock
December 7, 2025
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
December 5, 2025
Fulcrum Therapeutics to Host Investor Event to Review New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease on December 7, 2025
December 1, 2025
Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
November 2, 2025
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2025
October 28, 2025
Fulcrum Therapeutics to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Wednesday, October 29, 2025, at 8: 00 a.m. ET
October 21, 2025
Fulcrum Therapeutics to Present Preclinical Data for EED Inhibitor FTX-6274 at European Society for Medical Oncology (ESMO) Congress 2025
October 13, 2025
Fulcrum Therapeutics to Present at Upcoming Investor Meetings
August 25, 2025
Fulcrum Therapeutics Announces Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
July 29, 2025
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025
July 28, 2025
Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
July 27, 2025
Fulcrum Therapeutics to Present at Upcoming Medical Meetings
May 28, 2025
Fulcrum Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference
May 28, 2025
Fulcrum Therapeutics to Participate in Upcoming May Conferences
May 7, 2025
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2025
April 30, 2025
Fulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8: 00 a.m. ET
April 23, 2025
Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference
March 3, 2025
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2024
February 24, 2025
Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8: 00 a.m. ET
February 17, 2025
Fulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 5, 2025
Calls in 2025
Decks in 2025
- Technical Presentation (December 2025)
Technical · 31 slides · Dec 8, 2025
- Investor Presentation (August 2025)
Investor deck · 30 slides · Aug 28, 2025
- Technical Presentation (July 2025)
Technical · 31 slides · Jul 29, 2025
- Corporate Update (January 2025)
Corporate update · 21 slides · Jan 13, 2025